European Journal of Hospital Pharmacy-Science and Practice

Initial evaluation of a brief pharmacy-led intervention to modify beliefs about medicines and facilitate adherence among patients hospitalised with acute coronary syndrome

5PSQ-128 Pharmacotherapeutic profile and risk of drug-related problems and drug interactions in HIV+ patients of a health area

4CPS-009 Evaluation of the safety of inhibitors of the co-transporter 2 in a university care hospital

5PSQ-048 Real-world safety and tolerability of the recently commercialised palbociclib

4CPS-071 Shortage of drugs era: impact of piperacilin/tazobactam shortage

5PSQ-026 Impact of a safety alert with valsartan in a health management area

4CPS-068 Impact of the pharmaceutical recommendations for the improvement in antibiotics prescription

4CPS-256\u2005Linezolid usage and cost analysisafter a hospital transfer

Improving policies and practices for the extemporaneous compounding of oral liquid dosage forms in Saudi Arabian hospitals

4CPS-153\u2005Comparative analysis between originator and biosimilar infliximab according to trough levels in patients with inflammatory bowel disease

6ER-005 Use of sacubitril/valsartan in patients with chronic heart failure

5PSQ-163 Medication reconciliation in an emergency department

5PSQ-042\u2005Modification on fasting lipid and renal parameters in patients switching from tenofovir disoproxil to tenofovir alafenamide

4CPS-160\u2005Efficacy and safety of anakinra and canakinumab for the treatment of IL-36R antagonist deficiency

3PC-006\u2005Analysis of the regimens established at the pharmacy service for total parenteral nutrition and the use of glutamine as a source of nitrogen

4CPS-167\u2005Study of the use of tapentadol

4CPS-119 Experience of nab-paclitaxel and gemcitabine use in metastatic pancreatic cancer

6ER-020 Social authorities concerning #hospitalpharmacy on twitter

National audit of antidote stocking in UK emergency departments

5PSQ-092 Profile and complexity level of clinical trials in the pharmacy service

4CPS-202 Anticholinergical risk in chronic complex patients

2SPD-001\u2005Describing a thickener home delivery protocol and the benefits of its implementation

4CPS-092 Prevalence of polypharmacy in patients with human immunodeficiency virus infection

4CPS-150 Evaluation of intra-patient variability of the tacrolimus plasmatic levels in different periods after liver transplant

4CPS-039 Dupilumab treatment discontinuation due to limiting adverse effects: a case report

1ISG-005 A cost-effective strategy: switching from one to two tablets, in a once-daily regimen in HIV patients

3PC-049 Mobile applications related to parenteral nutrition: qualitative and quantitative analysis

4CPS-030 Analysis of adaptation to a protocol of use of the PCSK9 inhibitors

2SPD-031 Management of drug shortages in a tertiary hospital

4CPS-095 Rescue of patients infected with hepatitis C virus not responding to interferon-free therapies

4CPS-156 Safety profile of apremilast in psoriasis and psoriatic arthritis

5PSQ-109 Drug-related problems and their contribution to emergency department visits in polymedicated patients

3PC-051 Impact of ophthalmological preparations in the pharmacy service of a reference hospital

4CPS-093 Persistence of an antiretroviral therapy in human immunodeficiency virus patients in a tertiary level hospital

4CPS-045 Value of the clinical pharmacist in the pharmacokinetic monitoring of antimicrobials: health outcomes

5PSQ-057 Olaparib and niraparib safety profile in the clinical practice of a tertiary-level hospital

4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials

Cost-effectiveness of two technology-assisted manual medication picking systems versus traditional manual picking in a hospital outpatient pharmacy

5PSQ-143 Prevalence of potentially inappropriate prescriptions in institutionalised and non-institutionalised elderly patients

5PSQ-007 Sebelipase alfa as enzyme replacement therapy in three paediatric patients

5PSQ-160 Medication reconciliation in the emergency department in elderly patients

Antibiotic usage at a clinical paediatric hospital before and after the implementation of actions related to the hospital antibiotic policy

4CPS-033 The use of oral apremilast for the treatment of plaque psoriasis

4CPS-061 Extended infusion of meropenem in a neonate with complicated klebsiella pneumoniae meningitis

Vancomycin dose optimisation comparing a pharmacokinetic/pharmacodynamic model versus the pharmacokinetic model

5PSQ-152 Do we know the content of harmful excipients in medicines that neonates receive?

1ISG-009 Avoided cost study of drugs in clinical trials at a tertiary hospital